SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advanced Enzyme Technologies rises on acquiring 50% stake in Saiganesh Enzytech Solutions

04 Jan 2023 Evaluate

Advanced Enzyme Technologies is currently trading at Rs. 291.10, up by 6.25 points or 2.19% from its previous closing of Rs. 284.85 on the BSE.

The scrip opened at Rs. 290.00 and has touched a high and low of Rs. 294.00 and Rs. 288.95 respectively. So far 5443 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 355.15 on 04-Feb-2022 and a 52 week low of Rs. 257.00 on 25-Feb-2022.

Last one week high and low of the scrip stood at Rs. 305.00 and Rs. 274.00 respectively. The current market cap of the company is Rs. 3251.79 crore.

The promoters holding in the company stood at 49.87%, while Institutions and Non-Institutions held 27.28% and 22.85% respectively.

Advanced Enzyme Technologies has completed the acquisition of 50% stake in Saiganesh Enzytech Solutions (SESPL) by way of subscription to the issue of 19,991,663 Equity shares of SESPL on private placement/preferential issue basis, at a total consideration of Rs. 5.99 crore.
SESPL is primarily into extracting Latex from papaya, purifying and providing finish papain enzyme in liquid form (agriculture extraction of Papain enzyme).

Advanced Enzyme Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.

Advanced Enzyme Share Price

299.15 0.30 (0.10%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×